✦ LIBER ✦

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist

✍ Scribed by Hironori Yuyama; Masanao Sanagi; Akiko Koakutsu; Mikiko Mori; Akira Fujimori; Hironori Harada; Katsumi Sudoh; Keiji Miyata

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The orally active nonpeptide selective e

✍ Hironori Yuyama; Akira Fujimori; Masanao Sanagi; Akiko Koakutsu; Katsumi Sudoh; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 737 KB

ChemInform Abstract: Endothelin Antagoni

✍ W. W. K. R. MEDERSKI; D. DORSCH; M. OSSWALD; S. ANZALI; M. CHRISTADLER; C.-J. SC 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

Effect of single oral administration of

✍ Hironori Yuyama; Rie Sonoda; Kumiko Shibasaki; Akira Fujimori; Katsumi Sudoh; Ma 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 502 KB

In vitro and in vivo effects of endothel

✍ Masashi Ukai; Hironori Yuyama; Akira Fujimori; Akiko Koakutsu; Masanao Sanagi; A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Characterization of SB-271046: A potent,

✍ Carol Routledge; Steven M Bromidge; Stephen F Moss; Gary W Price; Warren Hirst; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Pharmacological profile of SB-357134: A

✍ Tania O Stean; Warren D Hirst; David R Thomas; Gary W Price; Derek Rogers; Graha 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 221 KB